ReviewCurrent diabetes reports2025

Targeting Metabolic Dysfunction in Parkinson's Disease: The Role of GLP-1 Agonists in Body Weight Regulation and Neuroprotection.

Iciar Aviles-Olmos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.